Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Desensitization and Tachyphylaxis
Drug Toxicity: Dose-Dependent Reactions
Toxidromes: Clinical Features
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 10, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Sean Patrick Nordt1, Jeffrey Zilberstein, Barry Gold
1Department of Emergency Medicine, University of Southern California, Los Angeles, CA, USA. spnordt@hotmail.com
No abstract available in PubMed .
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
10:41Laser-Induced Action Potential-Like Measurements of Cardiomyocytes on Microelectrode Arrays for Increased Predictivity of Safety Pharmacology
Published on: September 13, 2022